Evaluation of the Galα1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 4650-4656

  Welsh, Raymond M ^a   O'Donnell, Carey L ^a   Reed, Deborah J ^b   Rother, Russell P ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b ALEXION PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; GALACTOSYLTRANSFERASE; UNCLASSIFIED DRUG; EPITOPE; GLYCOSIDE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; HUMORAL IMMUNITY; MOUSE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SINDBIS VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS ENVELOPE; VIRUS EXPRESSION; VIRUS INACTIVATION; ANIMAL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; CELL LINE; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CELL LINE; EPITOPES; GLYCOSIDES; HERPESVIRUS 1, HUMAN; HUMANS; MICE; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0031596772     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.4650-4656.1998     Document Type: Article

References (46)

1. Almeida, J. D., and A. P. Waterson. 1969. The morphology of virus-antibody interaction. Adv. Virus Res. 15:307-338.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1991. Current protocols in molecular biology, vol. I. John Wiley & Sons, New York, N.Y.
3. Babu, J. S., J. Thomas, S. Kanagat, L. A. Morrison, D. M. Knipe, and B. T. Rouse. 1996. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J. Virol. 70:101-107.
4. Bartholomew, R. M., and A. F. Esser. 1998. Differences in activation of human and guinea pig complement by retroviruses. J. Immunol. 121:1748-1751.
5. Bartholomew, R. M., A. F. Esser, and H. J. Muller-Eberhard. 1978. Lysis of oncornaviruses by human serum: isolation of the viral component (C1) receptor and identification as p15E. J. Exp. Med. 147:844-853.
6. Beebe, D. P., and N. R. Cooper. 1981. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J. Immunol. 126:1562-1568.
7. Brutkiewicz, R. R., C. L. O'Donnell, J. W. Maciaszek, R. M. Welsh, and M. Vargas-Cortes. 1993. The mAb CZ-1 identifies a mouse CD45-associated epitope expressed on IL-2-responsive cells. Eur. J. Immunol. 23:2427-2433.
8. Bukowski, J. F., B. A. Woda, S. Habu, K. Okumura, and R. M. Welsh. 1983. Natural killer cell depletion enhances virus synthesis and virus induced hepatitis in vivo. J. Immunol. 131:1531-1538.
9. Cooper, N. R. 1991. Complement evasion strategies of microorganisms. Immunol. Today 12:327-331.
10. Cooper, N. R., F. C. Jensen, R. M. Welsh, and M. B. A. Oldstone. 1976. Lysis of RNA tumor viruses by human serum: direct antibody independent triggering of the classical complement pathway. J. Exp. Med. 144:970-984.
11. Cooper, N. R., and R. M. Welsh. 1979. Antibody and complement dependent viral neutralization. Semin. Immunopathol. 2:285-310.
12. Crise, B., A. Ruusala, P. Zagouras, A. Shaw, and J. K. Rose. 1989. Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein. J. Virol. 63:5328-5333.
13. Ebenbichler, C. F., N. M. Thielens, R. Vornhagen, P. Marschang, G. J. Arlaud, and M. P. Dierich. 1991. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174: 1417-1424.
14. Galili, U., K. E. Mandrell, R. M. Hamadeh, S. B. Shohet, and J. M. Griffis. 1988. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 56:1730-1737.
15. Galili, U., S. B. Shohet, E. Kobrin, C. L. M. Stults, and B. A. Macher. 1988. Man, apes, and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J. Biol. Chem. 263: 17755-17762.
16. Gallagher, R. E., A. W. Schrecker, C. A. Walter, and R. C. Gallo. 1978. Oncornavirus lytic activity in the serum of gibbon apes. J. Natl. Cancer Inst. 60:677-682.
17. Goochee, C. F., M. J. Gramer, D. C. Andersen, J. B. Baher, and J. R. Rasmussen. 1991. The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties. Bio/Technology 9:1347-1355.
18. Hicks, J. T., F. A. Ennis, E. Kim, and M. Verbonitz. 1978. The importance of an intact complement pathway in recovery from a primary viral infection. Influenza in decomplemented and in C5-deficient mice. J. Immunol. 121: 1437-1445.
19. Hirsch, R. L., D. E. Griffin, and J. A. Winkelstein. 1981. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance. J. Immunol. 127:1740-1743.
20. Hoshino, H., H. Tanaka, M. Miwa, and H. Okada. 1984. Human T-cell leukemia virus is not lysed by human serum. Nature 310:324-325.
21. Keegstra, K., B. Sefton, and D. Burke. 1975. Sindbis virus glycoproteins: effect of the host cell on oligosaccharides. J. Virol. 16:613-620.
22. Lenard, J. 1980. Lipids of alphaviruses, p. 335-341. In R. W. Schlesinger (ed.), The togaviruses. Academic Press, New York, N.Y.
23. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124.
24. Matloubian, M., S. R. Kolhekar, T. Somasundaram, and R. Ahmed. 1993. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the porymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67:7340-7349.
25. McGinnes, L. W., and T. G. Morrison. 1997. Disulfide bond formation is a determinant of glycosylation site usage in the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J. Virol. 71:3083-3089.
26. Miller, A. D., and C. Bultimore. 1997. Redesign of retrovirus packagining cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
27. Montenori, D. C., R. J. Cornell, J. Y. Zhou, V. M. Hirsch, and P. R. Johnson. 1994. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205:85-92.
28. Reed, D. J., X. Lin, T. D. Thomas, C. W. Birks, J. Tang, and R. P. Rother. 1997. Alteration of glycosylation renders HIV sensitive to inactivation by normal human serum. J. Immunol. 159:4356-4361.
29. Renkonen, O., L. Kaariainen, K. Simons, and C. G. Gahmberg. 1971. The lipid composition of Semliki Forest virus and of plasma membranes of the host cells. Virology 46:318-426.
30. Rother, R. P., W. L. Fodor, J. P. Springhorn, C. W. Birks, E. Setter, M. S. Sandrin, S. P. Squinto, and S. A. Rollins. 1995. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J. Exp. Med. 182:1345-1355.
31. Rother, R. P., S. A. Rollins, W. L. Fodor, J.-C. Albrecht, E. Setter, B. Fleckenstein, and S. P. Squinto. 1994. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J. Virol. 68:730-737.
32. Rother, R. P., and S. P. Squinto. 1996. The α-galactosyl epitope: a sugar coating that makes viruses and cells unpalatable. Cell 86:185-188.
33. Sefton, B., and B. J. Gaffney. 1974. Effect of viral proteins on the fluidity of membrane lipids in Sindbis virus. J. Mol. Biol. 90:343-358.
34. Sherwin, S. A., R. E. Benveniste, and G. J. Todaro. 1978. Complement-mediated lysis of C-type virus: effect of primate and human sera on various retroviruses. Int. J. Cancer 21:6-11.
35. Stollar, V. 1975. Immune lysis of Sindbis virus. Virology 66:620-624.
36. Takeuchi, Y., C. D. Porter, K. M. Strahan, A. F. Preece, K. Gustafsson, F.-L. Cosset, R. A. Weiss, and M. K. L. Collins. 1996. Sensitization of cells and retroviruses to human serum by (α1-3) galactosyltransferase. Nature 379:85-88.
37. Thall, A. D., P. Maly, and J. B. Lowe. 1995. Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 270:21437-21440.
38. Thieblemont, N., N. Haeffner-Cavaillon, A. Ledur, J. L'Age-Stehr, H. W. Ziegler-Heitbrock, and M. D. Kazatchkine. 1993. CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4. Clin. Exp. Immunol. 92:106-113.
39. Vaughan, H. A., B. E. Loveland, and M. S. Sandrin. 1994. Gala(1,3)gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic human antibodies. Transplantation 58:879-882.
40. Waite, M. R. F., and E. R. Pfefferkorn. 1968. Effect of altered osmotic pressure on the growth of Sindbis virus. J. Virol. 2:759-760.
41. Wedgwood, R. J., H. S. Ginsberg, and L. Pillemer. 1956. The properdin system and immunity. IV. The inactivation of Newcastle disease virus by the properdin system. J. Exp. Med. 104:707-725.
42. Welsh, R. M. 1977. Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement. J. Immunol. 118:348-354.
43. Welsh, R. M., and M. J. Buchmeier. 1979. Protein analysis of defective interfering lymphocytic choriomeningitis virus and persistently infected cells. Virology 96:503-515.
44. Welsh, R. M., N. R. Cooper, F. C. Jensen, and M. B. A. Oldstone. 1975. Human serum lyses RNA tumor viruses. Nature 257:612-614.
45. Welsh, R. M., F. C. Jensen, N. R. Cooper, and M. B. A. Oldstone. 1976. Inactivation and lysis of oncornaviruses by human serum. Virology 74:432-440.
46. Welsh, R. M., P. W. Lampert, P. A. Burner, and M. B. A. Oldstone. 1976. Antibody-complement interactions with purified lymphocytic choriomeningitis virus. Virology 73:59-71.